Eli Lilly and Company sponsored a symposium entitled 'Cardiac sexology: can we save a patient's life and his love life?' The aim of this meeting was not only to give participants valuable information about the etiologic links between erectile dysfunction (ED) and cardiovascular disease (CVD), but also to provide a glance into a future that I would like to call 'Cardiac Sexology' and how this might affect clinical practice. This supplement provides an overview of the three presentations and provides answers to some of the audience's questions.
At the European Society of Sexual Medicine (ESSM) annual meeting in November 2007, Eli Lilly and Company sponsored a symposium entitled 'Cardiac sexology: can we save a patient's life and his love life?' The aim of this meeting was not only to give participants valuable information about the etiologic links between erectile dysfunction (ED) and cardiovascular disease (CVD), but also to provide a glance into a future that I would like to call 'Cardiac Sexology' and how this might affect clinical practice. This supplement provides an overview of the three presentations and provides answers to some of the audience's questions.
In our first paper, Dr François Giuliano (France) reviews the latest research on endothelial dysfunction and ED, emphasizing the importance of knowing their connection. Penile erection, a complex neurovascular process, depends on the control of blood flow by endothelium-dependent vasodilatation. ED is predominantly a disease of vascular origin (mainly because of endothelial dysfunction). Endothelial dysfunction is also common in many other clinical conditions, providing a unifying link between CVD and ED. This article describes the epidemiology and pathophysiology of ED, as well as the close association of ED with CVD. In addition, evidence for ED as a valuable early marker for CVD, particularly in men with diabetes or those who are obese, is summarized.
I address the question of whether we can prevent CVD by early identification of ED in the second article. Up to two-thirds of men with clinically evident coronary artery disease have ED. As penile arteries have a much smaller diameter than other arteries, they are more sensitive to the damaging effects of plaque burden. Indeed, overwhelming evidence indicates that ED can precede coronary artery disease by an average of 2-3 years, and even by up to 5 years! Consequently, ED is now being viewed as a potential early warning sign of both acute and chronic coronary disease. Thus, there is a real opportunity to markedly reduce (or even prevent) CVD by identifying men with ED and no cardiac symptoms. Utilizing this information in conjunction with other risk factors could then provide a comprehensive cardiovascular risk management program early enough to significantly improve outcomes.
In the final paper, Dr Dimitrios Hatzichristou (Greece) synthesizes key learnings from earlier articles showing the importance and necessity of a holistic approach to health care in terms of an individual patient's overall health, sexual function and, ultimately, life satisfaction. Unfortunately, despite being a common condition significantly affecting sexual well-being and overall quality of life, ED is frequently under-recognized and underdiagnosed in clinical practice. The problem is multifactorial, including patient-and physicianrelated issues and the lack of a care model for ED management. This article discusses why development of a patient-centered (rather than diseasecentered) conceptual framework is fundamental to the prevention and management of ED in men with and without cardiac disease.
